Sasaki Jun | Committee For Epidemiology And Clinical Management Of Atherosclerosis

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy : Long-Term Efficacy and Safety in Japanese Patients With Hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a P
Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease : Secondary Prevention Analysis From JELIS
4 Effects of EPA on coronary artery disease in patients with gluco-metabolism derangement : JELIS subgroup analysis(Late Breaking Clinical Trials II,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
4 Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : Sub-analysis of primary prevention cases from JELIS(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanes
3 Effectiveness of eicosapentaenoic acid in preventing coronary artery disease : Secondary prevention strata from JELIS.(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Polymorphisms of Apolipoprotein E and Methylenetetrahydrofolate Reductase in the Japanese Population
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases
FRS-040 Relationships Between Coronary Artery Disease (CAD) and Serum Lipid Concentrations, and Preventive Effects of EPA in Hypercholesterolemic Patients : JELIS Sub-Analysis(Preventive Medicine, The 71st Annual Scientific Meeting of the Japanese Circula
Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia : Implications from the Japan Lipid Intervention Trial (J-LIT)
Prevalence of Metabolic Syndrome in the General Japanese Population in 2000
Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin
2 Major Outcomes and Safety of EPA Derived from the Japan EPA LIPID INTERVENTION STUDY (JELIS)(Late Breaking Clinical Trials in Japan,The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
The Risk of Cardiovascular Events in Japanese Hypertensive Patients with Hypercholesterolemia : Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a Large-Scale Observational Cohort Study
Polymorphisms in Four Genes Related to Triglyceride and HDL-cholesterol Levels in the General Japanese Population in 2000
Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: Sub-analysis of the Japan Lipid Intervention Trial (J-LIT)
Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000
Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients - Implication of the J-LIT study, a large scale nationwide cohort study
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease - Secondary prevention cohort study of the
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia - Primary prevention cohort study of the Japan lipid intervention tri
Strategy for treating elderly Japanese with hypercholesterolemia
Clinical Effects of Rosuvastatin, a New HMG-CoA Reductase Inhibitor, in Japanese Patients With Primary Hypercholesterolemia : an Early Phase II Study
Statement
Women
Elderly Patients
Treatment-Drug Therapy
Treatment-Therapeutic Lifestyle Modification
Primary Hyperlipidemia
Metabolic Syndrome
Risk Factors of Atherosclerotic Diseases : Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Goals of Dyslipidemia Management : Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Diagnostic Criteria for Dyslipidemia : Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Report of the Japan Atherosclerosis Society(JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
The Patient Characteristics of the Hyper-responder to Low Dose Statin Treatment in J-LIT Study
Preventive Effects of Eicosapentaenoic Acid on Coronary Artery Disease in Patients With Peripheral Artery Disease : Subanalysis of the JELIS Trial

もっと見る

スポンサーリンク